• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

筛选阻断 PD-1/PD-L1 相互作用的 threose 核酸适体用于癌症免疫治疗。

Selection of threose nucleic acid aptamers to block PD-1/PD-L1 interaction for cancer immunotherapy.

机构信息

Department of Biomedical Engineering, College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing, Jiangsu 210023, China.

出版信息

Chem Commun (Camb). 2020 Dec 4;56(93):14653-14656. doi: 10.1039/d0cc06032a. Epub 2020 Nov 6.

DOI:10.1039/d0cc06032a
PMID:33155587
Abstract

Threose nucleic acid (TNA) aptamers were selected in vitro to bind PD-L1 protein and inhibit its interaction with PD-1. These biologically stable TNA aptamers bound target proteins with nanomolar affinities, and effectively blocked PD-1/PD-L1 interaction in vitro. After injection into a colon cancer xenograft mouse model, the TNA aptamer N5 was specifically accumulated at the tumour site, and significantly inhibited tumour growth in vivo.

摘要

三碳核酸(TNA)适体在体外被筛选出来以结合 PD-L1 蛋白并抑制其与 PD-1 的相互作用。这些具有生物稳定性的 TNA 适体以纳摩尔亲和力结合靶蛋白,并有效地在体外阻断 PD-1/PD-L1 相互作用。在注射到结肠癌异种移植小鼠模型后,TNA 适体 N5 特异性地在肿瘤部位积聚,并显著抑制体内肿瘤生长。

相似文献

1
Selection of threose nucleic acid aptamers to block PD-1/PD-L1 interaction for cancer immunotherapy.筛选阻断 PD-1/PD-L1 相互作用的 threose 核酸适体用于癌症免疫治疗。
Chem Commun (Camb). 2020 Dec 4;56(93):14653-14656. doi: 10.1039/d0cc06032a. Epub 2020 Nov 6.
2
Selection of PD1/PD-L1 X-Aptamers.PD1/PD-L1 X-适体的筛选。
Biochimie. 2018 Feb;145:125-130. doi: 10.1016/j.biochi.2017.09.006. Epub 2017 Sep 11.
3
Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect.抗 PD-L1 DNA 适体拮抗 PD-1/PD-L1 的相互作用并具有抗肿瘤作用。
J Mater Chem B. 2021 Jan 28;9(3):746-756. doi: 10.1039/d0tb01668c.
4
Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer.PD-1/PD-L1 轴调节在三阴性乳腺癌治疗中的未来。
Pharmacol Res. 2022 Jan;175:106019. doi: 10.1016/j.phrs.2021.106019. Epub 2021 Dec 1.
5
Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.肽阻断 PD-1/PD-L1 相互作用用于癌症免疫治疗。
Cancer Immunol Res. 2018 Feb;6(2):178-188. doi: 10.1158/2326-6066.CIR-17-0035. Epub 2017 Dec 7.
6
Aptamer-assisted phage display: enhancing checkpoint inhibition with a peptide and an aptamer targeting distinct sites on a single PD-L1 protein.适体辅助噬菌体展示:利用靶向单个PD-L1蛋白上不同位点的肽和适体增强检查点抑制作用。
Chem Commun (Camb). 2024 Jul 18;60(59):7570-7573. doi: 10.1039/d4cc02132k.
7
Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-γ to evaluate the efficacy of PD-L1/PD-1-targeted immunotherapy.基于外周血单个核细胞和 IFN-γ 注射建立人源化肿瘤微环境小鼠模型,以评估 PD-L1/PD-1 靶向免疫治疗的疗效。
Cancer Biol Ther. 2020;21(2):130-138. doi: 10.1080/15384047.2019.1670520. Epub 2019 Nov 6.
8
Microbiota-Regulated Outcomes of Human Cancer Immunotherapy via the PD-1/PD-L1 Axis.微生物群通过PD-1/PD-L1轴调节人类癌症免疫治疗的结果。
Biochemistry. 2018 Feb 13;57(6):901-903. doi: 10.1021/acs.biochem.7b01249. Epub 2018 Jan 19.
9
PD-1/PD-L1 and immunotherapy for pancreatic cancer.PD-1/PD-L1 与胰腺癌的免疫治疗。
Cancer Lett. 2017 Oct 28;407:57-65. doi: 10.1016/j.canlet.2017.08.006. Epub 2017 Aug 18.
10
In vitro selection of an XNA aptamer capable of small-molecule recognition.体外筛选能够识别小分子的 XNA 适体。
Nucleic Acids Res. 2018 Sep 19;46(16):8057-8068. doi: 10.1093/nar/gky667.

引用本文的文献

1
Ligase-catalyzed transcription and reverse-transcription of XNA-containing nucleic acid polymers using T3 DNA ligase.使用T3 DNA连接酶进行的含XNA核酸聚合物的连接酶催化转录和逆转录。
Chem Sci. 2025 Mar 21. doi: 10.1039/d5sc00834d.
2
Identification of Podoplanin Aptamers by SELEX for Protein Detection and Inhibition of Platelet Aggregation Stimulated by C-Type Lectin-like Receptor 2.通过 SELEX 技术筛选鉴定 Podoplanin 适体用于 C 型凝集素样受体 2 刺激的血小板聚集的蛋白检测和抑制
Biosensors (Basel). 2024 Sep 27;14(10):464. doi: 10.3390/bios14100464.
3
Evolution of a bispecific G-quadruplex-forming circular aptamer to block IL-6/sIL-6R interaction for inflammation inhibition.
一种双特异性形成G-四链体的环状适体的进化,以阻断IL-6/sIL-6R相互作用来抑制炎症。
Chem Sci. 2024 Jul 17;15(32):13011-13020. doi: 10.1039/d4sc02183e. eCollection 2024 Aug 14.
4
Aptamer Screening: Current Methods and Future Trend towards Non-SELEX Approach.适配体筛选:非 SELEX 方法的现状和未来趋势。
Biosensors (Basel). 2024 Jul 18;14(7):350. doi: 10.3390/bios14070350.
5
Aptamers as an approach to targeted cancer therapy.适配体作为一种靶向癌症治疗的方法。
Cancer Cell Int. 2024 Mar 16;24(1):108. doi: 10.1186/s12935-024-03295-4.
6
The Expanded Central Dogma: Genome Resynthesis, Orthogonal Biosystems, Synthetic Genetics.扩展中心法则:基因组重合成、正交生物系统、合成遗传学。
Annu Rev Biophys. 2023 May 9;52:413-432. doi: 10.1146/annurev-biophys-111622-091203.
7
Aptamer-Based Strategies to Boost Immunotherapy in TNBC.基于适配体的三阴性乳腺癌免疫治疗增强策略
Cancers (Basel). 2023 Mar 28;15(7):2010. doi: 10.3390/cancers15072010.
8
Nucleic acid nanostructures for applications: The influence of morphology on biological fate.用于应用的核酸纳米结构:形态对生物命运的影响。
Appl Phys Rev. 2023 Mar;10(1):011304. doi: 10.1063/5.0121820.
9
bioTCIs: Middle-to-Macro Biomolecular Targeted Covalent Inhibitors Possessing Both Semi-Permanent Drug Action and Stringent Target Specificity as Potential Antibody Replacements.生物 TCIs:具有半永久药物作用和严格靶标特异性的中到大分子生物靶向共价抑制剂,可作为潜在的抗体替代品。
Int J Mol Sci. 2023 Feb 9;24(4):3525. doi: 10.3390/ijms24043525.
10
Functional Xeno Nucleic Acids for Biomedical Application.用于生物医学应用的功能性异种核酸。
Chem Res Chin Univ. 2022 Jul 5:1-7. doi: 10.1007/s40242-022-2186-7.